Hamilton Lane (NASDAQ:HLNE) Price Target Raised to $120.00

Hamilton Lane (NASDAQ:HLNE – Free Report) had its target price lifted by Keefe, Bruyette & Woods from $116.00 to $120.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The firm currently has an outperform rating on the stock.

Other research analysts have also issued research reports about the stock. UBS Group cut their price target on shares of Hamilton Lane from $131.00 to $115.00 and set a “buy” rating on the stock in a report on Tuesday, October 13th. Morgan Stanley set a $118.00 target price on shares of Hamilton Lane in a report on Friday, October 16th. The Goldman Sachs Group restated a “buy” rating and set a $117.00 price objective on shares of Hamilton Lane in a research note on Friday, October 2nd. Weiss Ratings upgraded Hamilton Lane from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, August 31st. Finally, Oppenheimer decreased their price target on Hamilton Lane from $182.00 to $181.00 and set an “outperform” rating on the stock in a research report on Thursday, August 27th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $126.12.

Get Our Latest Analysis on HLNE

Hamilton Lane Stock Down 0.7%

Shares of NASDAQ:HLNE opened at $89.46 on Wednesday. The company has a market capitalization of $4.97 billion, a P/E ratio of 13.27 and a beta of 1.16. Hamilton Lane has a 52-week low of $71.88 and a 52-week high of $155.66. The company has a quick ratio of 3.49, a current ratio of 3.49 and a debt-to-equity ratio of 0.16. The stock’s fifty day simple moving average is $89.41 and its 200-day simple moving average is $96.59.

Hamilton Lane (NASDAQ:HLNE – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.65 by $0.33. The business had revenue of $204.43 million during the quarter, compared to analyst estimates of $215.23 million. Hamilton Lane had a return on equity of 25.10% and a net margin of 32.14%. The firm’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.54 EPS. As a group, equities research analysts forecast that Hamilton Lane will post 7.61 earnings per share for the current fiscal year.

Hamilton Lane Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 7th. Stockholders of record on Monday, December 21st will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, December 21st. This represents a $2.40 annualized dividend and a dividend yield of 2.7%. Hamilton Lane’s dividend payout ratio (DPR) is currently 35.61%.

Institutional Trading of Hamilton Lane

A number of institutional investors have recently made changes to their positions in the business. Fort Washington Investment Advisors Inc. OH bought a new stake in Hamilton Lane during the 3rd quarter worth approximately $27,027,000. The Manufacturers Life Insurance Company lifted its holdings in shares of Hamilton Lane by 1,039.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 335,903 shares of the company’s stock valued at $33,389,000 after acquiring an additional 306,429 shares during the last quarter. Squarepoint Ops LLC acquired a new stake in Hamilton Lane in the second quarter worth about $24,063,000. Copeland Capital Management LLC lifted its holdings in Hamilton Lane by 52.5% during the third quarter. Copeland Capital Management LLC now owns 741,678 shares of the company’s stock valued at $64,422,000 after purchasing an additional 255,238 shares in the last quarter. Finally, Aberdeen Group plc purchased a new stake in Hamilton Lane in the third quarter valued at approximately $10,685,000. Institutional investors own 97.40% of the company’s stock.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated (NASDAQ: HLNE) is a global investment management firm specializing in private markets. The company provides investment solutions and advisory services focused on alternative assets, including private equity, private credit, venture capital, growth equity, infrastructure and real assets.

Hamilton Lane serves institutional investors, family offices, financial advisors and high-net-worth individuals. Its offerings include separately managed accounts, customized portfolios, commingled funds, evergreen vehicles and secondary-market strategies.

See Also

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.